Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David De Semir

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Journal of Personalized Medicine|December 29, 2022
Pitfalls and Rewards of Setting Up a Liquid Biopsy Approach for the Detection of Driver Mutations in Circulating Tumor DNAs: Our Institutional ExperienceMichelle Chen, Damon Jian, Maxim Sidorov, et al.
Molecular Cancer Therapeutics|July 13, 2023
Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug ExposuresStephen H Chang, Ryan J Ice, Michelle Chen, et al.
The Journal of Investigative Dermatology|February 21, 2021
Prevalence of Homologous Recombination Pathway Gene Mutations in Melanoma: Rationale for a New Targeted Therapeutic ApproachKevin B Kim, Liliana Soroceanu, David de Semir, et al.
British Journal of Cancer|December 21, 2019
Drug responses are conserved across patient-derived xenograft models of melanoma leading to identification of novel drug combination therapiesRyan J Ice, Michelle Chen, Max Sidorov, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Journal of Personalized Medicine|December 29, 2022
Pitfalls and Rewards of Setting Up a Liquid Biopsy Approach for the Detection of Driver Mutations in Circulating Tumor DNAs: Our Institutional ExperienceMichelle Chen, Damon Jian, Maxim Sidorov, et al.
Molecular Cancer Therapeutics|July 13, 2023
Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug ExposuresStephen H Chang, Ryan J Ice, Michelle Chen, et al.
The Journal of Investigative Dermatology|February 21, 2021
Prevalence of Homologous Recombination Pathway Gene Mutations in Melanoma: Rationale for a New Targeted Therapeutic ApproachKevin B Kim, Liliana Soroceanu, David de Semir, et al.
British Journal of Cancer|December 21, 2019
Drug responses are conserved across patient-derived xenograft models of melanoma leading to identification of novel drug combination therapiesRyan J Ice, Michelle Chen, Max Sidorov, et al.
Pageof 4